Market access strategies and plans start early in product development to optimally design programs that generate relevant evidence. That is best practice – early integrated regulatory and market access strategies are critical to success. By planning early and well, your team can play chess, not tennis, with decision-makers.
Dr Laurie Smaldone Alsup, MD, COO/CSO of NDA Group will discuss:
- Insight into the HOW to avoid market delays that impact patients and ultimately reimbursement
- The importance of early planning, pressure testing and preparation for the make or break end game
- How to convince payers that your product brings important value to patients and to the system.
In addition, she will share proven methods to critique and provide strategy through expert panels that pressure test the pivotal trials designs and value documentation. These methods can help align companies internally and efficiently focus investments. Cross functional teams that can benefit from these strategies include regulatory, clinical, outcomes research, marketing, market access, commercial and medical affairs operations.